Integrin ß1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway.

Deng, Qin-Fang; Su, B O; Zhao, Yin-Min; Tang, Liang; Zhang, Jie; Zhou, Cai-Cun.

Afiliação

Deng QF; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, P.R. China; Department of Oncology, School of Medicine, Soochow University, Suzhou 215007, P.R. China.
Su BO; Central Laboratory, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, P.R. China.
Zhao YM; Central Laboratory, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, P.R. China.
Tang L; Central Laboratory, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, P.R. China.
Zhang J; Central Laboratory, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, P.R. China.
Zhou CC; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, P.R. China.

Oncol Lett ; 11(1): 535-542, 2016 Jan.

Article em En | MEDLINE | ID: mdl-26870244